Accommodative spasm. Disorders of accommodation
Conditions
Interventions
Intervention 1: Intervention group: Patients with anxiety are treated with fluoxetine 20 for 5 weeks, and in the fifth week, patients are treated with vision therapy under the supervision of an optome
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 30 Years
Inclusion criteria
Inclusion criteria: Having eye spasms with symptoms Bilateral accommodative spasm (there should be conditions in both eyes and it should not be unilateral) No history of underlying diseases Absence of strabismus
Exclusion criteria
Exclusion criteria: Uncorrected hyperopia Having systemic diseases Having pathological anxiety Having eye diseases such as keratoconus, cataract, uveitis, retinal retinopathy, and all diseases that affect the quality of vision and visual system of the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dry refractive error. Timepoint: At the beginning of the study (before the start of the intervention), 5 weeks after the start of fluoxetine, and 3 months after the start of vision therapy. Method of measurement: Autorefractometer device.;Cyclo refractive error. Timepoint: At the beginning of the study (before the start of the intervention), 5 weeks after the start of fluoxetine, and 3 months after the start of vision therapy. Method of measurement: Autorefractometer device.;Best corrected visual acuity. Timepoint: At the beginning of the study (before the start of the intervention), 5 weeks after the start of fluoxetine, and 3 months after the start of vision therapy. Method of measurement: Glasses or contact lenses. | — |
Secondary
| Measure | Time frame |
|---|---|
| Amplitude of accommodation. Timepoint: En At the beginning of the study (before the start of the intervention), 5 weeks after the start of fluoxetine, and 3 months after the start of vision therapy. Method of measurement: Dynamic retinoscopy.;Facility of accommodation. Timepoint: En At the beginning of the study (before the start of the intervention), 5 weeks after the start of fluoxetine, and 3 months after the start of vision therapy. Method of measurement: Dynamic retinoscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrdad Sadeghi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed